Leading U.S. urologists have been appointed to new posts at the University of Minnesota, Minneapolis; NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York; and Rhode Island Hospital/The Miriam Hospital, Providence.
Leading U.S. urologists have been appointed to new posts at the University of Minnesota, Minneapolis; NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York; and Rhode Island Hospital/The Miriam Hospital, Providence.
The University of Minnesota Medical School has named Badrinath Konety, MD, as professor and chair of its department of urologic surgery. A native of India, Dr. Konety attended medical school at Bangalore University before coming to the United States as a research fellow in 1991 at the VA Medical Center, San Fransisco. He completed his residency training and an American Foundation for Urologic Diseases fellowship at the University of Pittsburgh, where he also earned an MBA.
Dr. Konety’s main research interests include the screening, treatment, and management of prostate and bladder cancer.
Ashutosh Tewari, MD, has been appointed as director of the new Prostate Cancer Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Tewari is an internationally acclaimed expert on robotic prostatectomy and other minimally invasive robotic surgeries, of which he has performed more than 2,000 in New York. His clinical interests include urologic oncology, including prostate and bladder cancer.
Dr. Tewari will continue to serve as director of the recently established LeFrak Center for Robotic Surgery and as director of robotic prostatectomy and prostate cancer–urologic oncology outcomes at NewYork-Presbyterian/Weill Cornell Medical Center.
Mark Sigman, MD, has been appointed chief of urology at Rhode Island Hospital and The Miriam Hospital. Dr. Sigman will be responsible for organizing and managing the clinical services, educational and research activities, and administration of the division of urology.
Dr. Sigman, a urologist at both Rhode Island and The Miriam hospitals, will continue to serve as co-director of the Men’s Health Center at The Miriam. He also will oversee the division of urology in the department of surgery of the Warren Alpert Medical School of Brown University, Providence, where he is a professor of surgery (urology).
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.